Impact Factor
4.15
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.77
2,466 total citations
h5-index
63
h5 depth signal
Cited share
58.2%
224 of 385
Total citations
2,466
Citation footprint
Metric signal
8.01
External metric anchor
Self-citation
1.5%
37 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
395
United Kingdom
108
Germany
96
China
56
Netherlands
46
Citing Fields of Research
Cardiology
405
Immunology
162
Cell Biology
143
Physiology
123
Stem Cell Biology
117
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
885
Articles tracked across the journal lifetime
Indexed publication set
385
224 cited publications
Last 12 months
163
13.6 publications/month
Open access share
27.0%
44 OA publications in the last year
Leading citing country
United States
395 citing publications
Leading citing field
Cardiology
405 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2022-
v1n1, Jan. 2022-
Selected citations only
Research Focus & Classification
Indexed Subjects
Cardiology
Immunology
Stem Cell Biology
Genetics & Genomics
Cell Biology
Cell Differentiation & Development
Broad Categories
Cardiology
Vascular Diseases
Immunology
Cancer & Development
Genetics & Genomics
Hematology
Lipids
MeSH Descriptors
Cardiovascular Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s44161-026-00886-4
Open DOI
Deep learning-enabled assessment of right ventricular size and function is associated with cardiovascular outcomes
02
DOI 10.1038/s44161-026-00890-8
Open DOI
A multiview video–text model detects obstructive coronary stenosis and predicts 1-year cardiovascular events from angiography
Invasive coronary angiography is the reference standard for diagnosing coronary artery disease, yet assessment is subjective, and existing artificial-intelligence tools typically assess stenosis in individual frames or videos and do not ...
03
DOI 10.1038/s44161-026-00885-5
Open DOI
Human adult and pediatric multimodal transcriptomic atlas of progression from pressure-loaded to failing right ventricle
Right ventricular failure (RVF) independently predicts mortality in heart failure, yet its pathophysiology is poorly understood. Here we present a multi-modal atlas of human right ventricular pressure loading and failure, including bulk ...
04
DOI 10.1038/s44161-026-00893-5
Open DOI
Refining stress echocardiography reduces the need for invasive testing in heart failure with preserved ejection fraction
05
DOI 10.1038/s44161-026-00882-8
Open DOI
All-fiber wireless auscultation garment for cardiopulmonary diagnostics
Daily apparel could enable continuous, noninvasive monitoring of cardiopulmonary health for the early detection and treatment of cardiopulmonary diseases, the leading causes of death and disability worldwide. Here we develop an all-fiber...
06
DOI 10.1038/s44161-026-00884-6
Open DOI
Therapeutic upregulation of gene expression in inherited cardiomyopathies from current approaches to future directions
07
DOI 10.1038/s44161-026-00881-9
Open DOI
A metabolic–epigenetic switch governs multicellular cardiac repair following succinate dehydrogenase inhibition
Cardiac regeneration is limited in the adult mammalian heart because of restricted cardiomyocyte proliferation and persistent fibrosis. We previously demonstrated that transient pharmacological inhibition of succinate dehydrogenase (SDH)...
08
DOI 10.1038/s44161-026-00875-7
Open DOI
A failing heart is a failing heart — until proteomics looks beyond etiology
09
DOI 10.1038/s44161-026-00880-w
Open DOI
Cardiac proteomic and phosphoproteomic profiling defines clinically relevant molecular subgroups in human heart failure
Molecular heterogeneity in heart failure (HF) is increasingly recognized as a major barrier to effective therapy development. Here we performed proteomic profiling of left ventricular tissues from 149 patients with advanced HF spanning n...
10
DOI 10.1038/s44161-026-00854-y
Open DOI
Gut microbiome shifts in chronic systolic heart failure are associated with disease severity and clinical improvement
The contribution of the gut microbiome to chronic heart failure (HF) remains poorly defined. We performed integrated microbiome and host multi-omic profiling of adults with chronic systolic HF due to nonischemic cardiomyopathy ( n = 59) ...